Objectives To evaluate the prophylactic efficacy of the human papillomavirus (HPV)
quadrivalent vaccine in preventing low grade cervical, vulvar, and vaginal intraepithelial …

Objectives To determine the effect of human papillomavirus (HPV) quadrivalent vaccine on
the risk of developing subsequent disease after an excisional procedure for cervical …

Objective To measure the effectiveness of the quadrivalent human papillomavirus (HPV)
vaccine against cervical abnormalities four years after implementation of a nationally funded …

Background: Previous analyses from a randomised trial in women aged 24–45 years have
shown the quadrivalent human papillomavirus (qHPV) vaccine to be efficacious in the …

Aim Prophylactic human papillomavirus (HPV) vaccines are highly effective at preventing
pre–cancerous cervical lesions when given in a three–dose schedule. Some post–hoc trial …

Background Optimised two-dose human papillomavirus (HPV) vaccine schedules are now
endorsed for young adolescents by the World Health Organization. Limited data are …

Objective The goal of this study was to review the current human papillomavirus (HPV)
vaccine program and its outcomes to date in Australia. Methods This was a review of the …

Objective To assess the potential epidemiological and economic impact of a prophylactic
quadrivalent human papillomavirus (HPV)(6/11/16/18) vaccine for preventing cervical …

Quadrivalent human papillomavirus (HPV) vaccine has been shown to provide protection
from HPV 6/11/16/18–related cervical, vaginal, and vulvar disease through 3 years. We …

Background A phase 3 trial was conducted to evaluate the efficacy of a prophylactic
quadrivalent vaccine in preventing anogenital diseases associated with human …